Overall Bottom Line Autoimmune liver conditions such as AIH, PBC and PSC all recur post-LT but graft loss is uncommon. Patients with HBV do extremely well post-LT because of the…
Overall Bottom Line The most frequent CR is preceded by one or more episodes of AR that are often resistant to corticosteroid therapy and require anti-lymphocyte or other rescue therapy….
Overall Bottom Line The prevention of bacterial, fungal and viral infections after LT is essential to successful outcomes. Early recognition of infection is essential for implementing the appropriate treatment strategy…
Overall Bottom Line Patients with underlying acute and chronic liver disease are at risk of morbidity and mortality after surgery. The magnitude of the risk is related to the severity…
Overall Bottom Line WD, also known as hepatolenticular degeneration, is a rare autosomal recessive systemic disorder caused by defective copper metabolism. It most commonly presents with isolated hepatic, neurological or…
Overall Bottom Line HBV infection is a significant global health problem. Chronic hepatitis B is a major cause of cirrhosis, fulminant hepatitis and HCC worldwide. Chronic hepatitis B is responsible…
Overall Bottom Line Routine monitoring of liver tests throughout the early and late post-transplantation period is essential in screening for allograft dysfunction. Many causes of graft dysfunction including rejection and…
Overall Bottom Line With recipients living longer after undergoing LT, it has been noted that significant causes of morbidity and mortality post-transplantation are not related to recurrent liver disease. The…
Overall Bottom Line Due to long-term immunosuppression therapy, the post-LT recipient is at risk for disease conditions (e.g. infection, malignancy) that are generally regulated by the body’s immune system. Skin…
Overall Bottom Line LT, by necessity, subjects the liver allograft to ischemia followed by reperfusion. The pattern and severity of IRI that ensues may be clinically irrelevant in the majority…
